Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Trial pipeline

Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.

Free access · No subscription for research tools or data exports

Filter the development pipeline

Reset

13 trials match this view; 32 reported facilities; 32 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 875 across 13 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

20232
20242
20252
20267

Current indexed registry status

Recruiting6
Active, not recruiting3
Not yet recruiting1
Completed1
Terminated1
Unknown status1

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Milestones to investigate

The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.

For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.

Matching trial records

13 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans

NCT05876481

PTSD
Combat Stress

PHASE2

Unknown status

Registry updated 2023-05-25

8

ESTIMATED

2023-06
2025-07
2025-08
Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial

NCT05554094

PTSD · Stress Disorders, Traumatic · Stress Disorders, Post-Traumatic · Trauma and Stressor Related Disorders · Mental Disorder
Ohio State University

PHASE2

Completed

Registry updated 2026-10-16

12

ACTUAL

2023-01-01
2025-12-31
2026-07-31
Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects

NCT06624137

OCD · Major Depressive Disorder (MDD) · Alcohol Use Disorder (AUD) · Healthy Volunteer · Migraine · PTSD · PTSD - Post Traumatic Stress Disorder · Addiction · Tobacco Use Disorder · Obsessive Compulsive Disorder (OCD) · Opioid Use Disorder
Yale University

Phase not reported

Terminated

Registry updated 2026-07-09

5

ACTUAL

2024-12-12
2026-06-14
2026-06-14
An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD

NCT07275970

PTSD
Scottsdale Research Institute

PHASE1

Active, not recruiting

Registry updated 2026-07-29

24

ESTIMATED

2026-03-20
2026-07-30
2026-10-01
PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)

NCT06853912

Alcohol Use Disorder (AUD) · PTSD
Nathan Brashares Sackett

PHASE2

Active, not recruiting

Registry updated 2026-08-13

40

ESTIMATED

2025-06-01
2026-11-01
2027-06-01
The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma

NCT06888128

PTSD
Baylor College of Medicine

PHASE2

Recruiting

Registry updated 2026-01-22

15

ESTIMATED

2025-01-30
2026-12-15
2026-12-15
The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD

NCT07332143

PTSD
Emory University

PHASE2

Recruiting

Registry updated 2026-10-01

150

ESTIMATED

2026-06-08
2027-03
2027-03
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder

NCT07506395

PTSD
University of New Mexico

PHASE1

Recruiting

Registry updated 2026-05-22

36

ESTIMATED

2026-05-01
2027-05-01
2028-05-01
A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)

NCT06902974

Post Traumatic Stress Disorder · PTSD
Sunstone Medical

PHASE2

Recruiting

Registry updated 2026-07-01

70

ESTIMATED

2026-05-23
2027-11
2028-05
Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study

NCT06442423

Transdiagnostic · Depression - Major Depressive Disorder · Anxiety · PTSD Symptoms · PTSD · Substance Use · Substance Use Disorder (SUD) · OCD
Yale University

PHASE1

Recruiting

Registry updated 2026-11-16

50

ESTIMATED

2024-10-17
2027-12
2027-12
Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial

NCT06386003

Post Traumatic Stress Disorder · PTSD · Chronic PTSD
Unity Health Toronto

PHASE2

Active, not recruiting

Registry updated 2026-10-06

15

ESTIMATED

2026-06-01
2028-01
2028-06
A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

NCT07570654

PTSD - Post Traumatic Stress Disorder · PTSD · PTSD Symptoms · PTSD, Post Traumatic Stress Disorder
COMPASS Pathways

PHASE2, PHASE3

Recruiting

Registry updated 2026-11-12

300

ESTIMATED

2026-09-14
2028-11
2029-09
Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

NCT07745569

PTSD · PTSD - Post Traumatic Stress Disorder · Major Depression · Suicidality
University of New Mexico

PHASE2

Not yet recruiting

Registry updated 2026-10-30

150

ESTIMATED

2026-12-31
2030-06-30
2030-06-30

Reported research facilities

BCKamloops, British Columbia, Canada · Coordinates available
BCNorth Vancouver, British Columbia, Canada · Coordinates available
BCPenticton, British Columbia, Canada · Coordinates available
St. Michael's Hospital, Unity Health TorontoToronto, Ontario, Canada · Coordinates available
Combat StressLeatherhead, Surrey, United Kingdom · Coordinates available
AZTucson, Arizona, United States · Coordinates available
Baylor College of MedicineHouston, Texas, United States · Coordinates available
CAIrvine, California, United States · Coordinates available
CALos Angeles, California, United States · Coordinates available
CAMoorpark, California, United States · Coordinates available
CASan Jose, California, United States · Coordinates available
Connecticut Mental Health CenterHamden, Connecticut, United States · Coordinates available
Connecticut Mental Health Center - Yale School of MedicineNew Haven, Connecticut, United States · Coordinates available
Emory University HospitalAtlanta, Georgia, United States · Coordinates available
FLMiami, Florida, United States · Coordinates available
FLOrlando, Florida, United States · Coordinates available
ILChicago, Illinois, United States · Coordinates available
Interdisciplinary Substance Use and Brain Injury (ISUBI)Albuquerque, New Mexico, United States · Coordinates available
MABoston, Massachusetts, United States · Coordinates available
MNEden Prairie, Minnesota, United States · Coordinates available
NELincoln, Nebraska, United States · Coordinates available
NVLas Vegas, Nevada, United States · Coordinates available
NYNew York, New York, United States · Coordinates available
NYThe Bronx, New York, United States · Coordinates available
OHNorth Canton, Ohio, United States · Coordinates available
Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research CenterColumbus, Ohio, United States · Coordinates available
Scottsdale Research InstituteScottsdale, Arizona, United States · Coordinates available
Sunstone Medical, PCRockville, Maryland, United States · Coordinates available
TXCarrollton, Texas, United States · Coordinates available
UTOrem, Utah, United States · Coordinates available
University of Washington Center for Novel Therapeutics in Addiction PsychiatrySeattle, Washington, United States · Coordinates available
West Haven VA Medical CenterWest Haven, Connecticut, United States · Coordinates available

This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.